Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 601–650 of 900 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04171219	Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers	terminated	Phase 2	31	M.D. Anderson Cancer CenterOTHER	1	May 16, 2025	clinicaltrials
NCT05132842	Cannabis Use Patterns Among Cancer Patients	completed	—	1,568	Thomas Jefferson UniversityOTHER	1	May 15, 2025	clinicaltrials
NCT05600556